Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservative-free Cosopt in OAG/OH with dry eyes
NCT00545064Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- May 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of dorzolamide + timolol in open-angle glaucoma (OAG) and ocular hypertension, sponsored by Merck & Co. Primary endpoint: Glaucoma Symptom Scale-SYMP-6 at 8 weeks. Started May 2007; status: completed.
02
Drugs
dorzolamide + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00545064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545064.